Agios to Present at March Investor Conferences
- Cowen 41st Annual
Virtual Healthcare Conferenceon Monday, March 1, 2021at 11:40 a.m. ET; and
- Oppenheimer 31st Annual
Virtual Healthcare Conferenceon Wednesday, March 17, 2021at 9:20 a.m. ET.
Live webcasts of the presentations can be accessed under "Events & Presentations" in the Investors section of the company's website at www.agios.com. Replays of the webcasts will be archived on the Agios website for at least two weeks following each presentation.
Agios is focused on discovering and developing novel investigational medicines to treat malignant hematology, solid tumors and genetically defined diseases through scientific leadership in the field of cellular metabolism. In addition to an active research and discovery pipeline across these three therapeutic areas, Agios has two approved oncology precision medicines and multiple first-in-class investigational therapies in clinical and/or preclinical development. For more information, please visit the company's website at www.agios.com.
Investors & Media:
Director, Investor Relations
Source: Agios Pharmaceuticals, Inc.